The DIA Annual Canadian Meeting will deliver a comprehensive overview of the current bio-pharma and device landscape in Canada, while sharing insights into Canada’s broader role in global healthcare product development. From policy updates and priorities shared directly from Health Canada, to sessions on international work sharing and partnerships to key regulatory and clinical considerations for drugs and devices, you will have the exclusive opportunity to address the current issues and opportunities in Canada and across the globe.
Bringing together key stakeholders from the drug/device and Patient Self Care industries, regulatory agencies, and academia, this meeting will discuss and analyze the relevant challenges and opportunities for professionals working in the field in Canada.
Key Takeaways from the 2018 Meeting
- Access to Health Canada Officials
- CADTH Participation
- Multi-stakeholder perspectives
- Forward-looking sessions
- Comprehensive discussions around R2D2
While we work to develop this year’s agenda check out our 2018 Program!
Travel Once, Learn Twice!Receive $150 off your registration fee when you register for the DIA Annual Canadian Meeting and the Canadian Advertising and Promotion Regulatory Affairs Conference or the DIA Annual Canadian Meeting and the Canadian Pharmacovigilance and Risk Management Conference!